Turtle Creek Wealth Advisors’s Medpace MEDP Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$1.53K	–	559
2023 Q4	$1.53K	Buy	+5	New	+$1.35K	﹤0.01%	806

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Turtle Creek Wealth Advisors's MEDP Position: Q1 2024 in Review

Turtle Creek Wealth Advisors sold out of Medpace (MEDP) in Q1 2024, closing a stake of 5 shares — an estimated $1.53K sold.

Turtle Creek Wealth Advisors first reported a position in MEDP in Q4 2023 and held it in 1 quarter. The position peaked at $1.53K in Q4 2023. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

Turtle Creek Wealth Advisors reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
Turtle Creek Wealth Advisors sold 5 Medpace shares in Q1 2024, an estimated $1.53K.
Turtle Creek Wealth Advisors first reported a position in Medpace in Q4 2023 and held it in 1 quarter.
Turtle Creek Wealth Advisors's Medpace position peaked at $1.53K in Q4 2023.
597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.